UBC PiMS Research Group (the Tremlett Laboratory)
Pharmacoepidemiology in Multiple Sclerosis Research Group (the Tremlett Laboratory)

ECTRIMS 2021

The disease-modifying drugs for multiple sclerosis and association with survival.

Authors: H.S. Ng, F. Zhu, E. Kingswell, S. Yao, O. Ekuma, C. Evans, J.D. Fisk, R.A. Marrie, H. Tremlett.

Presentation Type: Oral Presentation.

Global incidence of multiple sclerosis has not increased in the last three decades: a systematic review (1985-2020)

Authors: J. Lane, H.S. Ng, C. Poyser, R.M. Lucas, H. Tremlett.

Presentation Type: Poster Presentation

Emergency department visits by persons with MS: a population- based study

Authors: J. Graf, H.S. Ng, F. Zhu, Y. Zhao, J. MA Wijnands, C. Evans, J.D. Fisk, R.A. Marries, O. Aktas, P. Albrecht, H.P. Hartung, S.G. Meuth, H. Tremlett.

Presentation Type: Poster Presentation

FUNDED – free registration.

a place of mind, The University of British Columbia

Pharmacoepidemiology in MS (PiMS)
2211 Wesbrook Mall,
Vancouver, BC, V6T 2B5, Canada
Email:

Emergency Procedures | Accessibility | Contact UBC  | © Copyright The University of British Columbia